Twist Bioscience Net Income Over Time
| TWST Stock | USD 49.11 1.45 3.04% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Twist Bioscience Performance and Twist Bioscience Correlation. Is there potential for Biotechnology market expansion? Will Twist introduce new products? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.27) | Revenue Per Share | Quarterly Revenue Growth 0.169 | Return On Assets | Return On Equity |
Investors evaluate Twist Bioscience Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Twist Bioscience's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Twist Bioscience's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Twist Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Twist Bioscience's market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Net Income Analysis
Compare Twist Bioscience Corp and related stocks such as Procept Biorobotics Corp, Quidel, and Qilian International Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PRCT | (42 M) | (42 M) | (42 M) | (42 M) | (42 M) | (42 M) | (42 M) | (42 M) | (42 M) | (42 M) | (53 M) | (59.9 M) | (87.2 M) | (105.9 M) | (91.4 M) | (82.3 M) | (86.4 M) |
| QDEL | (100 K) | 7.6 M | 5 M | 7.4 M | (7.1 M) | (6.1 M) | (13.8 M) | (8.2 M) | 74.2 M | 72.9 M | 810.3 M | 704.2 M | 548.7 M | (10.1 M) | (2.1 B) | (1.1 B) | (1.1 B) |
| BGM | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 5.2 M | 5.3 M | 5.1 M | 3.2 M | 1.1 M | (7.8 M) | (1.4 M) | (1.4 M) | (1.3 M) | (1.2 M) |
| GRDN | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 21.7 M | 19.9 M | 16.3 M | 35.4 M | 23.9 M | (87.3 M) | (78.6 M) | (74.6 M) |
| MESO | (1.5 M) | (71.1 M) | (61.7 M) | (81 M) | (119.4 M) | (4.1 M) | (76.8 M) | (35.3 M) | (89.8 M) | (77.9 M) | (98.8 M) | (91.3 M) | (81.9 M) | (88 M) | (102.1 M) | (91.9 M) | (87.3 M) |
| EWTX | (9.5 M) | (9.5 M) | (9.5 M) | (9.5 M) | (9.5 M) | (9.5 M) | (9.5 M) | (9.5 M) | (9.5 M) | (9.5 M) | (17.1 M) | (42.1 M) | (15.4 M) | (100.2 M) | (133.8 M) | (120.4 M) | (114.4 M) |
| QURE | (22.4 M) | (22.4 M) | (19.5 M) | (37 M) | (45 M) | (78.1 M) | (73.4 M) | (80.4 M) | (83.3 M) | (124.2 M) | (125 M) | 329.6 M | (126.8 M) | (308.5 M) | (239.6 M) | (215.6 M) | (204.8 M) |
| GPCR | (15.9 K) | (15.9 K) | (15.9 K) | (15.9 K) | (15.9 K) | (15.9 K) | (15.9 K) | (15.9 K) | (15.9 K) | (15.9 K) | (15.9 K) | (40 M) | (51.3 M) | (89.6 M) | (122.5 M) | (110.3 M) | (104.8 M) |
| VRDN | (7.2 M) | (7.2 M) | (7.2 M) | (2.2 M) | (7.9 M) | (11.3 M) | (12.7 M) | (26.5 M) | (32.7 M) | (41.9 M) | (110.7 M) | (79.4 M) | (129.9 M) | (237.7 M) | (269.9 M) | (243 M) | (230.8 M) |
| CLOV | (201.9 M) | (201.9 M) | (201.9 M) | (201.9 M) | (201.9 M) | (201.9 M) | (201.9 M) | (201.9 M) | (201.9 M) | (363.7 M) | (136.4 M) | (587.8 M) | (339.6 M) | (213.4 M) | (43 M) | (49.5 M) | (51.9 M) |
Twist Bioscience Corp and related stocks such as Procept Biorobotics Corp, Quidel, and Qilian International Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Twist Bioscience Corp financial statement analysis. It represents the amount of money remaining after all of Twist Bioscience Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Twist Bioscience Corp | TWST |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 681 Gateway Boulevard, |
| Exchange | NASDAQ Exchange |
USD 49.11
Additional Tools for Twist Stock Analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.